risperidone has been researched along with Fatty Liver, Nonalcoholic in 4 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In conclusion, long-term administration of risperidone may exacerbate diabetes syndrome, nonalcoholic fatty liver disease, and kidney injury." | 5.62 | Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice. ( Chang, CC; Chang, GR; Chou, LS; Hou, PH; Hsiao, LW; Liao, HJ; Lin, TC; Mao, FC; Tsai, HP; Wu, CF; Yang, WC, 2021) |
| "Non-alcoholic fatty liver disease (NAFLD) incidence is higher in patients with schizophrenia and is exacerbated with antipsychotic treatment." | 5.56 | Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. ( Beauchemin, M; Bernier, E; Bouchard, C; Houseknecht, KL; May, M; Rostama, B; Vary, CPH, 2020) |
| "A 59-year-old man with nonalcoholic steatohepatitis cirrhosis underwent an orthotopic liver transplant and experienced a complicated postoperative course, including a prolonged delirium." | 5.43 | Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. ( Brown, GD; Muzyk, AJ; Preud'homme, XA, 2016) |
| " In conclusion, long-term administration of risperidone may exacerbate diabetes syndrome, nonalcoholic fatty liver disease, and kidney injury." | 1.62 | Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice. ( Chang, CC; Chang, GR; Chou, LS; Hou, PH; Hsiao, LW; Liao, HJ; Lin, TC; Mao, FC; Tsai, HP; Wu, CF; Yang, WC, 2021) |
| "Non-alcoholic fatty liver disease (NAFLD) incidence is higher in patients with schizophrenia and is exacerbated with antipsychotic treatment." | 1.56 | Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice. ( Beauchemin, M; Bernier, E; Bouchard, C; Houseknecht, KL; May, M; Rostama, B; Vary, CPH, 2020) |
| "A 59-year-old man with nonalcoholic steatohepatitis cirrhosis underwent an orthotopic liver transplant and experienced a complicated postoperative course, including a prolonged delirium." | 1.43 | Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine. ( Brown, GD; Muzyk, AJ; Preud'homme, XA, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rostama, B | 1 |
| Beauchemin, M | 1 |
| Bouchard, C | 1 |
| Bernier, E | 1 |
| Vary, CPH | 1 |
| May, M | 1 |
| Houseknecht, KL | 1 |
| Tsai, HP | 1 |
| Hou, PH | 1 |
| Mao, FC | 1 |
| Chang, CC | 1 |
| Yang, WC | 1 |
| Wu, CF | 1 |
| Liao, HJ | 1 |
| Lin, TC | 1 |
| Chou, LS | 1 |
| Hsiao, LW | 1 |
| Chang, GR | 1 |
| Brown, GD | 1 |
| Muzyk, AJ | 1 |
| Preud'homme, XA | 1 |
| Morlán-Coarasa, MJ | 1 |
| Arias-Loste, MT | 1 |
| Ortiz-García de la Foz, V | 1 |
| Martínez-García, O | 1 |
| Alonso-Martín, C | 1 |
| Crespo, J | 1 |
| Romero-Gómez, M | 1 |
| Fábrega, E | 1 |
| Crespo-Facorro, B | 1 |
1 trial available for risperidone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Metabolic Diseases; Midd | 2016 |
3 other studies available for risperidone and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice.
Topics: Animals; Antipsychotic Agents; Chemical and Drug Induced Liver Injury, Chronic; Liver; Male; Mice; M | 2020 |
Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice.
Topics: Adipocytes; Adiponectin; Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Ca | 2021 |
Prolonged Delirium With Catatonia Following Orthotopic Liver Transplant Responsive to Memantine.
Topics: Catatonia; Delirium; Excitatory Amino Acid Antagonists; Humans; Liver Transplantation; Male; Memanti | 2016 |